Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 54 entries
Sorted by: Best Match Show Resources per page
Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.

Postepy w kardiologii interwencyjnej = Advances in interventional cardiology

Kurzyna M, Darocha S, Koteja A, Pietura R, Torbicki A.
PMID: 25848362
Postepy Kardiol Interwencyjnej. 2015;11(1):1-4. doi: 10.5114/pwki.2015.49176. Epub 2015 Mar 06.

No abstract available.

2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension.

Revista espanola de cardiologia (English ed.)

Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M.
PMID: 26837729
Rev Esp Cardiol (Engl Ed). 2016 Feb;69(2):177. doi: 10.1016/j.rec.2016.01.002.

No abstract available.

Varenicline-Induced Panic Disorder in a Previously Healthy Patient.

The Annals of pharmacotherapy

Nomani S, Torbicki K, Mihic T.
PMID: 29363353
Ann Pharmacother. 2018 May;52(5):499. doi: 10.1177/1060028018755162. Epub 2018 Jan 24.

No abstract available.

Assessment of Clinical Usefulness of Resting Electrocardiogram (PH-ECG Score) in Monitoring the Efficacy of Balloon Pulmonary Angioplasty (BPA) in Patients with Chronic Thromboembolic Pulmonary Hypertension (CTEPH).

Journal of clinical medicine

Piłka M, Mańczak M, Darocha S, Banaszkiewicz M, Mańczak R, Florczyk M, Kędzierski P, Pietrasik A, Balsam P, Kurzyna P, Wasilewski M, Wolański R, Torbicki A, Kurzyna M.
PMID: 34640565
J Clin Med. 2021 Sep 30;10(19). doi: 10.3390/jcm10194548.

BACKGROUND: Balloon pulmonary angioplasty (BPA) is a form of therapy for chronic thromboembolic pulmonary hypertension (CTEPH). The study objective is to assess the clinical usefulness of resting ECG (PH-ECG score) in monitoring the efficacy of BPA in CTEPH patients.METHODS...

Drawing light from the pandemic: Rethinking strategies for health policy and beyond.

Health policy (Amsterdam, Netherlands)

Forman R, Azzopardi-Muscat N, Kirkby V, Lessof S, Nathan NL, Pastorino G, Permanand G, van Schalkwyk MC, Torbica A, Busse R, Figueras J, McKee M, Mossialos E.
PMID: 34961678
Health Policy. 2021 Dec 05; doi: 10.1016/j.healthpol.2021.12.001. Epub 2021 Dec 05.

The COVID-19 pandemic is a catastrophe. It was also preventable. The potential impacts of a novel pathogen were foreseen and for decades scientists and commentators around the world warned of the threat. Most governments and global institutions failed to...

Soluble ST2 as a Biomarker for Early Complications in Patients with Chronic Thromboembolic Pulmonary Hypertension Treated with Balloon Pulmonary Angioplasty.

Diagnostics (Basel, Switzerland)

Banaszkiewicz M, Pietrasik A, Florczyk M, Kędzierski P, Piłka M, Mańczak R, Kochman J, Opolski G, Torbicki A, Kurzyna M, Darocha S.
PMID: 33467121
Diagnostics (Basel). 2021 Jan 16;11(1). doi: 10.3390/diagnostics11010133.

BACKGROUND: The aim of the study was to assess soluble ST2 (sST2) concentration and its dynamic changes in the periprocedural period in patients with chronic thromboembolic pulmonary hypertension (CTEPH) treated with balloon pulmonary angioplasty (BPA).METHODS: We prospectively analyzed 57...

A new strategy for health and sustainable development in the light of the COVID-19 pandemic.

Lancet (London, England)

Monti M, Torbica A, Mossialos E, McKee M.
PMID: 34516953
Lancet. 2021 Sep 18;398(10305):1029-1031. doi: 10.1016/S0140-6736(21)01995-4. Epub 2021 Sep 10.

No abstract available.

Prostacyclin Analogues Inhibit Platelet Reactivity, Extracellular Vesicle Release and Thrombus Formation in Patients with Pulmonary Arterial Hypertension.

Journal of clinical medicine

Gąsecka A, Banaszkiewicz M, Nieuwland R, van der Pol E, Hajji N, Mutwil H, Rogula S, Rutkowska W, Pluta K, Eyileten C, Postuła M, Darocha S, Huczek Z, Opolski G, Filipiak KJ, Torbicki A, Kurzyna M.
PMID: 33801460
J Clin Med. 2021 Mar 02;10(5). doi: 10.3390/jcm10051024.

(1) Background: Prostacyclin analogues (epoprostenol, treprostinil, and iloprost) induce vasodilation in pulmonary arterial hypertension (PAH) but also inhibit platelet function. (2) Objectives: We assessed platelet function in PAH patients treated with prostacyclin analogues and not receiving prostacyclin analogues. (3)...

Characteristics and outcomes of patients with chronic thromboembolic pulmonary hypertension in the era of modern therapeutic approaches: data from the Polish multicenter registry (BNP-PL).

Therapeutic advances in chronic disease

Kopeć G, Dzikowska-Diduch O, Mroczek E, Mularek-Kubzdela T, Chrzanowski Ł, Skoczylas I, Tomaszewski M, Peregud-Pogorzelska M, Karasek D, Lewicka E, Jacheć W, Gąsior Z, Błaszczak P, Ptaszyńska-Kopczyńska K, Mizia-Stec K, Biederman A, Zieliński D, Przybylski R, Kędzierski P, Waligóra M, Roik M, Grabka M, Orłowska J, Araszkiewicz A, Banaszkiewicz M, Sławek-Szmyt S, Darocha S, Magoń W, Dąbrowska-Kugacka A, Stępniewski J, Jonas K, Kamiński K, Kasprzak JD, Podolec P, Pruszczyk P, Torbicki A, Kurzyna M.
PMID: 33854746
Ther Adv Chronic Dis. 2021 Mar 25;12:20406223211002961. doi: 10.1177/20406223211002961. eCollection 2021.

BACKGROUND: Significant achievements in the treatment of chronic thromboembolic pulmonary hypertension (CTEPH) have provided effective therapeutic options for most patients. However, the true impact of the changed landscape of CTEPH therapies on patients' management and outcomes is poorly known....

Apixaban and Dalteparin for the Treatment of Venous Thromboembolism in Patients with Different Sites of Cancer.

Thrombosis and haemostasis

Agnelli G, Muñoz A, Franco L, Mahé I, Brenner B, Connors JM, Gussoni G, Hamulyak EN, Lambert C, Suero MR, Bauersachs R, Torbicki A, Becattini C.
PMID: 34530482
Thromb Haemost. 2021 Sep 16; doi: 10.1055/s-0041-1735194. Epub 2021 Sep 16.

Efficacy and safety of anticoagulant treatment for venous thromboembolism (VTE) may vary in patients with different cancer sites. We evaluated the rates of VTE recurrence and major bleeding and the relative efficacy and safety of 6-month treatment with oral...

Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Hypertension: A Multicenter Registry.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Darocha S, Roik M, Kopeć G, Araszkiewicz A, Furdal M, Lewandowski M, Jacheć W, Grabka M, Banaszkiewicz M, Piertrasik A, Pietura R, Stępniewski J, Waligóra M, Magoń W, Jonas K, Łabyk A, Potępa M, Fudryna A, Jankiewicz S, Sławek-Szmyt S, Mularek-Kubzdela T, Lesiak M, Mroczek E, Orłowska J, Peregud-Pogorzelska M, Tomasik A, Mizia-Stec K, Przybylski R, Podolec P, Zieliński D, Biederman A, Torbicki A, Pruszczyk P, Kurzyna M.
PMID: 34219663
EuroIntervention. 2021 Jul 06; doi: 10.4244/EIJ-D-21-00230. Epub 2021 Jul 06.

BACKGROUND: Balloon pulmonary angioplasty (BPA) is a promising therapy for patients with chronic thromboembolic pulmonary hypertension (CTEPH) who are ineligible for pulmonary endarterectomy.AIMS: The present study evaluated the safety and efficacy of BPA for CTEPH using the first multicentre...

Prediction of Prognostic Hemodynamic Indices in Pulmonary Hypertension Using Non-Invasive Parameters.

Diagnostics (Basel, Switzerland)

Mańczak R, Kurzyna M, Piłka M, Darocha S, Florczyk M, Wieteska-Miłek M, Mańczak M, Torbicki A.
PMID: 32867292
Diagnostics (Basel). 2020 Aug 27;10(9). doi: 10.3390/diagnostics10090644.

Effective targeted therapy of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) requires regular risk stratification. Among many prognostic parameters, three hemodynamic indices: right atrial pressure, cardiac index, and mixed venous saturation are considered critically important for...

Showing 1 to 12 of 54 entries